News Releases

Results of a new study by researchers at Mayo Clinic and Washington State University show that hydrogen peroxide-producing e-bandages may be an effective alternative to antibiotics for managing infected wounds.  

Diagnostic tests are a critical part of America’s health infrastructure and helping people live healthier lives. But in a recent op-ed published on RealClearPolicy, William Morice II, M.D., president of Mayo Clinic Laboratories and Matt Sause, president and CEO of Roche Diagnostics North America, explain how the well-intended Protecting Access to Medicare Act of 2014 (PAMA) puts vital diagnostic tests at risk.

Mayo Clinic Laboratories has validated the Centers for Disease Control and Prevention's test kit for monkeypox and will begin to ramp up testing.

Mayo Clinic is the first and only PCD Foundation accredited center for the diagnosis of primary ciliary dyskinesia, a rare and debilitating lung disease.

Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in developing and implementing new tests — but never on such an aggressive timeline.

The Department of Health and Human Services has named Mayo Clinic Laboratories as one of five commercial laboratories to expand access and capacity for monkeypox testing.

Today's Highlights Include: Walz signs ALS bill by senator with the disease, Health Fusion: A farm family's journey from tragedy to gratefulness through organ donation, and google Search will soon let you book checkups and other medical appointments.

Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research published in Mayo Clinic Proceedings. The test is now available through Mayo Clinic Laboratories.

Starting mid-November, you will notice enhancements to MayoClinicLabs.com. We are building a better website for you, our clients, to ensure the best experience possible. We’re moving toward a simpler, more intuitive and customized experience, making it easier to do business with us.

Dr. Bobbi Pritt recently joined the Board of Governors of the College of American Pathologists — the world's largest organization of board-certified pathologists.

The NIH has awarded $40 million to Mayo Clinic to develop a comprehensive biorepository as the source of clinical samples for long COVID research studies.

Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory in Mayo Clinic’s Division of Clinical Microbiology, considers the prospects for COVID-19 this fall as the traditional influenza season ramps up.

Mayo Clinic and Thermo Fisher have joined forces to bring innovative solutions to patients.